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The cell cycle inhibitor p16INK4A (also known as
cyclin-dependent kinase inhibitor 2A) is expressed in vivo
in many tissues with age. The exposure of certain chronic
stresses can trigger p16INK4A expression and a
senescence-like phenotype. We studied whether p16INK4A
expression is induced in glomerular disease (GD). We
performed p16INK4A immunostaining on 35 biopsies with GD,
12 tubulointerstitial nephritis (TIN), and 19 normal live donor
kidneys at transplantation. Based on values for 42 normal
kidneys, we calculated expected nuclear p16INK4A expression
for age and compared the observed values in diseased
kidneys to those expected for age. In GD, p16INK4A expression
was strikingly increased in glomerular and interstitial cell
nuclei compared to normals and TIN, and could not be
attributed to age (Po0.05). By multivariate analyses, GD was
independently associated with increased nuclear p16INK4a
expression in glomeruli (Po0.001) and interstitium (P¼ 0.01).
The p16INK4A expression in glomerular and interstitial cell
nuclei, and tubular cytoplasm was higher in kidneys with
proteinuria and with atrophy/fibrosis (Po0.05). Older age was
associated with increased nuclear p16INK4a expression in tubules
(P¼ 0.01), and interstitial inflammation was associated with
increased nuclear p16INK4a expression in interstitial cells
(P¼ 0.001). The p16INK4a staining in tubular cytoplasm was
increased in both GD and TIN compared to normals (Po0.001),
and was not related to age (P40.05). Thus, kidneys with GD
display increased expression of senescence marker p16INK4A in
glomerular and interstitial cell nuclei compared to kidneys with
normal aging or TIN. The findings suggest a role for somatic cell
senescence mechanisms in progression of GD.
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The finite limitations in the survival and maintenance of
somatic cells could play a role in progressive renal disease and
in the development of renal insufficiency in renal trans-
plants.1 Cellular senescence refer to an in vitro phenotype of
cultured somatic cells that show permanent and irreversible
replication arrest. The features of this state include telomere
shortening (in humans) and a sustained increase in the
expression of cyclin-dependent kinase inhibitor p16INK4A,
also known as cyclin-dependent kinase inhibitor 2A or
CDKN2A.2,3 Recently, we showed that aged human kidneys
in vivo show some features of cellular senescence manifested
by cultured somatic cells and p16INK4A emerged with the
best correlation with kidney age. In addition, p16INK4A was
significantly associated with glomerulosclerosis, interstitial
fibrosis (IF), and tubular atrophy (TA), some of the principal
histological features of renal senescence.4 In addition to
replicative stress and normal aging, a number of environ-
mental stresses, such as DNA damage and oxidative stress,
X-rays, ultraviolet irradiation, H2O2, and ectopic expression
of certain oncogenes and tumor suppressor genes can trigger
a senescence-like phenotype in mammalian cells, known as
extrinsic senescence.5–9 Many clinical nephrology problems
arise in the elderly, including high frequency of end-stage
renal disease, could involve an interaction between somatic
cell senescence and disease stresses that could accelerate the
limitations on the capacity of aged nephron to cope with
various injury, repair, and maintain epithelial functions. This
may contribute to the acceleration of renal senescence
phenotype by age-related diseases, such as hypertension
and heart failure.5,10 It is also possible that the exposure of
certain types of chronic stresses themselves may induce
senescence-like changes, even independent of age. The role of
cell-cycle regulatory proteins and senescence mechanisms in
chronic renal stresses, such as primary glomerular disease
(GD), proteinuria, and hypertension remains unknown. We
recently showed that chronic deteriorating kidney transplants
show accelerated p16INK4A expression, correlating with IF/TA
and impaired function.1 Increased p16INK4A expression and/
or other cellular senescence elements could cause the
development of atrophy and fibrosis, thus might be relevant
to the progression of chronic renal diseases.
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It is probable that GD creates an environmental stress on
glomerular cells that exceeds what they would normally
experience during aging. Abnormal stresses could include
cytokines, growth factors, and reactive oxygen species derived
from intrinsic glomerular cells and inflammatory cells.
Glomerular injury frequently results in proteinuria and
filtered proteins are potential mediators of tubular epithelial
cell injury, contributing to chronic tubulointerstitial changes
and progression of GD.11–13 All these disease stresses could
theoretically accelerate some senescence changes, including
p16INK4A expression in stressed cells, which in turn may limit
their function and capacity to replicate and recover. In the
present study, we examined whether GD with proteinuria
show enhanced expression of p16INK4A compared to
tubulointerstitial nephritis (TIN) and normal implantation
biopsies.
RESULTS
p16INK4a protein expression in normal kidneys
The demographic and clinical data from controls (implanta-
tion biopsies) and diseased kidneys are given in Tables 1 and
2. In keeping with our previous reports,4 normal kidneys
showed p16INK4a staining in 2.572.8% of glomerular nuclei,
11.977.7% of tubular nuclei, and 6.477.2% of interstitial
cell nuclei. In addition to the nuclear staining, four of 19
normal kidneys (21%) showed tubular cytoplasmic p16INK4a
expression (mean score: 0.270.4). The mean score for
nuclear p16INK4a staining in arteries was 0.370.6 (Table 3).
Representative stainings are shown in Figure 1a, g, and k.
p16INK4a protein expression in GD
GD cases showed a strikingly increased p16INK4a expression
in glomerular nuclei (GD: 17.1712.2% vs normal kidneys:
2.572.8%; Po0.001) (Figure 1b–e), interstitial cell nuclei
(GD: 30.1724% vs normal kidneys: 6.477.2%; Po0.001)
(Figure 1h and i), and tubular cytoplasm (GD: 80% of cases,
mean score: 1.370.9 vs normal kidneys: 21% of cases, mean
score: 0.270.4; Po0.001) (Figure 1h and i; Table 3). The
number of p16INK4a-positive nuclei in tubules and arteries
was not different in GD vs normal kidneys (P40.05)
(Table 3, Figure 1h, i and l).
p16INK4a protein expression in TIN
The demographic data are given in Table 1. TIN biopsies
showed higher p16INK4a staining in interstitial cell nuclei
(13.879.4%, P¼ 0.001) and tubular cytoplasm (mean score:
1.571, Po0.001) (Figure 1j) compared to normal kidneys,
but the number of p16INK4a positive nuclei in tubules and
arteries was not significantly different between normal
kidneys and TIN (P40.05) (Table 3). The trivial increase
in glomerular p16INK4a in TIN compared to normals (4.673
vs 2.572.8%; P¼ 0.047) (Figure 1f) probably reflects aging
(mean age: 52.8720.5 vs 36.479.6) (Table 3).
Comparison of nuclear p16INK4a expression in GD and
TIN (Table 3) revealed that GD showed higher p16INK4a
staining in glomerular (P¼ 0.001) and interstitial cell nuclei
(P¼ 0.02).
Comparison of measured with expected p16INK4a expression
We used regression formulas with age derived from 42
normal kidney specimens, as previously published,4 to
calculate the expected p16INK4a expression for each biopsy
in the current study.
For normal kidneys (implantation biopsies), measured
and expected p16INK4a expression was not significantly
different (P40.05; Figure 2; Figure S1), that is, p16INK4a
expression at implantation was as expected for the age of the
donor.
Kidneys with GD showed increased p16INK4a expression in
glomerular and interstitial cell nuclei beyond that expected
for age (for glomeruli, measured: 17.1712.2% vs expected:
4.370.7%; for interstitial cells, measured: 30.1724% vs
expected: 7.373.5%) (Po0.001; Figure 2; Figure S1).
In TIN biopsies, the measured p16INK4a expression was
similar to the amount predicted for age in glomerular nuclei
(4.673 vs 4.570.8%; P¼ 0.90), but was higher in interstitial
cell nuclei (13.879.4 vs 8.273.7%; P¼ 0.04) and lower in
tubular nuclei (776.3 vs 22.278.8%; Po0.001) (Figure 2;
Figure S1) than the amount predicted by age.
Univariate and multivariate linear regression analysis for
nuclear p16INK4a expression
By univariate linear regression analysis, p16INK4a expression
in glomerular and interstitial cell nuclei was associated with
Table 1 | Demographic and clinical data on groups from which kidney biopsies were derived
Normal kidneysa TIN Glomerular disease
(n=19) (n=12) (n=35)
Kidney (donor) age (years) 36.479.6 52.8720.5* 47.9719.5*
Kidney (donor) gender (m/f) 8/11 2/10 23/12
Creatinine (mmol/l) 74.8716.8 399.97352.3* 122.6791.8*
Proteinuria (g/l/24 h) 0.1270.03 0.6870.86* 5.473.7*
IF/TA 0.1570.37 1.3370.88* 1.6070.7*
IF, interstitial fibrosis; TA, tubular atrophy; TIN, tubulointerstitial nephritis.
IF/TA was assessed from 0 to 3.
Values are given as mean7s.d.
*Significant difference between normal kidneys and TIN, glomerular disease (Mann–Whitney, Po0.05).
aNormal kidney tissue samples were obtained from live donor biopsies at the time of transplantation. Recipient age: 43.5717.5 years, recipient gender (m/f): 13/6.
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GD, proteinuria, and IF/TA (Po0.05; Table 4). In addition,
age correlated with nuclear p16INK4a expression in glomerular
cells and interstitial inflammation correlated with nuclear
p16INK4a expression in interstitial cells (Po0.05; Table 4).
Serum creatinine at the time of biopsy did not correlate with
nuclear p16INK4a staining (P40.05). Age was the only
determinant of nuclear p16INK4a expression in tubules
(P¼ 0.01, Table 4) and arteries (P¼ 0.03, R2¼ 0.070)
(P40.05).
Using multivariate linear regression analysis, GD was
found the best independent contributor of increased p16INK4a
expression in glomeruli (Po0.001, R2¼ 0.432; Table 4;
Figure 3). For p16INK4a expression in interstitial cells, GD
(P¼ 0.01) and interstitial inflammation (P¼ 0.001);
R2¼ 0.456 emerged as independent determinants (Table 4).
p16INK4a staining in tubular cytoplasm
As mentioned above, p16INK4a staining in tubular cytoplasm
was significantly increased in GD and TIN compared to
normals. When all patients were included, cytoplasmic
tubular p16INK4a staining correlated with proteinuria
(P¼ 0.002, r¼ 0.385), serum creatinine at biopsy
(P¼ 0.004, r¼ 0.352), IF/TA (P¼ 0.002, r¼ 0.375), and
interstitial inflammation (P¼ 0.001, r¼ 0.407) but not with
age (P40.05).
When only patients with GD were analyzed, proteinuria
did not correlate with p16INK4a expression in glomerular,
tubular, interstitial cell nuclei, and tubular cytoplasm
(P40.05). However, IF/TA correlated with the amount of
Table 2 | Demographic and clinical data of the patients with proteinuria
Patient no Biopsy no
Age
(years) Sex
Proteinuria
(g/l/24 h)
Creatinine at biopsy
(lmol/l) Diagnosis
Last creatinine
(lmol/l)
Follow-up after the
biopsy (months)
1 1 39 M 10.0 113 MGP 121 12
2 1 87 F 3.5 108 MGP 129 7
3 1 56 M 4.3 84 MGP 117 15
4 1 41 M 3.5 69 MGP 95 63
5 1 57 F 2.0 75 MGP 66 39
6 1 80 M 2.2 86 MGP 76 45
7 1 35 M 3.6 88 MGP 95 30
8 1 73 F 9.5 86 MGP 105 4
9 1 68 F 3.5 76 MGP 62 20
10 1 44 M 17.4 83 MGP 339 46
2 47 9.0 200 MGP — 0
11 1 27 F 2.0 27 MGP 35 18
12 1 39 F 5.0 83 MGP 139 60
2 44 3.4 139 MGP 155 6
13 1 59 M 3.5 75 MGP 106 13
14 1 39 F 0.17 81 MGP 784 27
15 1 35 M 10.6 69 MGP 100 28
16 1 20 M 8.5 94 MGP 91 14
17 1 64 M 8.0 94 MGP 02 19
18 1 48 M 4.0 86 MGP 97 19
19 1 18 M 10.0 81 MGP 400 38
2 21 11.0 400 MGP 147 9
20 1 39 M 3.5 80 MCD 86 90
21 1 70 F 2.5 60 MCD 65 43
22 1 76 M 6.0 101 MCD 112 58
23 1 70 F 7.5 130 MCD 138 2
24 1 38 M 4.4 100 MCD 98 4
25 1 48 M 3.5 80 FSGS 120 47
26 1 15 M 3.5 90 FSGS 350 17
2 17 1.0 350 FSGS 1232 23
27 1 47 M 1.6 97 FSGS 83 52
28 1 26 F 4.0 68 FSGS 91 32
29 1 54 F 1.0 70 FSGS 98 75
30 1 66 M 9.6 300 FSGS 640 17
31 1 71 M 3.5 171 FSGS 145 73
FSGS, focal segmental glomerular sclerosis; MCD, minimal change disease; MGP, membranous glomerulopathy.
Table 3 | Comparison of p16INK4a expression in normal
kidneys, TIN, and GD.
p16INK4a expression (%, mean7s.d.)
Normal kidneys TIN Glomerular disease
(n=19) (n=12) (n=35)
Glomeruli-N 2.572.8 4.673 17.1712.2**
Tubules-N 11.977.7 7.076.3 17.3720
Tubules-Ca 0.270.4 1.571** 1.370.9**
Interstitium-N 6.477.2 13.879.4** 30.1724**
Arteries-Na 0.370.6 0.570.4 0.570.5
C, cytoplasmic staining; GD, glomerular disease; TIN, tubulointerstitial nephritis; N,
nuclear.
Normal kidneys were compared to TIN or GD. **Pp0.001 Mann–Whitney U test.
ap16INK4a positivity scores (mean7s.d.).
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p16INK4a expression in tubular nuclei and interstitial cell
nuclei (Po0.05).
p16INK4a staining in glomerular cell types
We further analyzed nuclear p16INK4a expression in glomeruli
by cell type and found that nuclear p16INK4a staining
occurred in all glomerular cell types including
mesangial–endothelial cells, podocytes, and parietal cells
(Figure 1 and Table 5). Nuclear p16INK4a staining in
mesangial–endothelial cells was increased in GD when
compared to normal kidneys and TIN (P¼ 0.04).
However, the increase in p16INK4a-positive podocyte and
a b c
d e f
g h i
j k l
Figure 1 | p16INK4a expression in normal kidneys and glomerular disease biopsies. (a–f) Glomerular p16INK4a expression: (a) Normal kidney
biopsy from a 42-year-old living related donor with rare p16INK4a staining in mesangial cells (arrowhead) and parietal epithelium (arrow).
(b) MGP biopsy from an 18-year-old boy, showing increased nuclear staining in mesangial–endothelial cells (short arrow), parietal epithelium,
and juxtaglomerular apparatus, including macula densa (arrowhead) and extraglomerular mesangium (long arrow). This biopsy from an
18-year-old boy has strikingly more p16INK4a staining than the 42-year normal kidney seen in a. (c) Another glomerulus from the same biopsy
seen in b, showing increased p16INK4a staining in parietal epithelium (arrow), podocytes (arrowheads), and mesangial–endothelial cells. (d) FSGS
biopsy from a 48-year-old man, showing increased p16INK4a staining in mesangial–endothelial cells (long arrow), podocytes (arrowhead), and
parietal epithelium (short arrow). (e) MCD from a 39-year-old man, showing p16INK4a staining in some mesangial–endothelial cells (long arrow),
podocytes (arrowheads), and parietal cells (short arrow). (f) TIN from a 26-year-old female showing occasional p16INK4a staining in
mesangial–endothelial cells (arrow). (g–j) Tubulointerstitial p16INK4a expression. (g) Normal kidney biopsy from a 42-year-old living related
donor with p16INK4a staining in some tubular cell nuclei. (h) MGP biopsy from a 64-year-old man showing intense cytoplasmic and nuclear
p16INK4a staining in some tubules and p16INK4a staining interstitial cell nuclei (arrows). p16INK4a staining in tubular cytoplasm and interstitial cell
nuclei is greatly increased in comparison to normal kidneys. (i) FSGS biopsy from a 48-year-old man, showing increased p16INK4a staining in
some tubules and interstitial cell nuclei (arrows). (j) TIN from a 26-year-old female, showing p16INK4a staining in some tubules and interstitial cell
nuclei (arrow). (k, l) Arterial p16INK4a expression. (k) Normal kidney biopsy from a 42-year-old living related donor with nuclear p16INK4a staining
in an artery. Arrows indicate smooth muscle cell nuclei in media. (l) MGP biopsy from an 18-year-old-boy, showing nuclear p16INK4a staining in
endothelial cells (arrow) and smooth muscle cells (arrowhead) of an artery.
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parietal cell nuclei in GD was not statistically significant
(P40.05).
p16INK4a staining in different types of GD
The overall expression of p16INK4a in glomeruli, interstitium,
tubules, and arteries was not significantly different among
membranous glomerulopathy (MGP), focal segmental glo-
merular sclerosis (FSGS), and minimal change disease
(MCD) (P40.05) (Table 6). Nuclear staining for p16INK4a
was detected in all three glomerular cell types in MGP (Figure
1b and c), FSGS (Figure 1d), and MCD (Figure 1e). The
amount of p16INK4a positive mesangial–endothelial cell,
podocyte, and parietal cell nuclei was similar in MGP, FSGS,
and MCD (P40.05; Table 7). Thus, both immune complex
mediated (MGP) and non-immune complex mediated GD
(FSGS and MCD) showed a similar pattern and amount of
glomerular p16INK4a expression.
Of the 35 GD, nine showed a mild increase in mesangial
matrix (eight MGP, one MCD) and seven showed a mild
mesangial hypercellularity (five MGP, one FSGS, one MCD).
None of the biopsies with GD showed glomerular inflamma-
tion. The presence of mesangial matrix expansion and mild
hypercellularity did not correlate with p16INK4a expression in
glomeruli, tubules, interstitium, or arteries (P40.05).
For cases with MGP, stage and underlying mechanism
(idiopathic vs secondary) did not relate to p16INK4a
expression in any compartment (P40.05). In three of eight
FSGS, the representative sections stained for p16INK4a showed
occasional segmental sclerotic lesions. First, the p16INK4a
staining in these segmentally sclerotic glomeruli was mainly
observed in non-sclerotic tuft area rather than the sclerotic
lesion (may be because of the hypo/acellular nature of the
lesion). Second, the amount of p16INK4a staining appeared to
be similar in glomeruli with or without segmental sclerosis,
but the number of sclerotic glomeruli was not enough to do a
statistical comparison.
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Figure 2 | Comparison of measured with expected p16INK4a
expression. Expected p16INK4a expression was calculated based on
the regression formulas derived from 42 normal kidneys as described
in Statistics. p16INK4a expression is shown in glomerular, tubular, and
interstitial cell nuclei. Normal kidneys (N) (implantation biopsies):
There was no difference between measured and expected p16INK4a
expression for all compartments. TIN biopsies: measured nuclear
p16INK4a expression in TIN biopsies was similar to the amount
expected in glomeruli, but was higher in interstitial cells and was
lower in tubules. GD biopsies: measured nuclear p16INK4a expression
in glomerular and interstitial cells was significantly higher than the
amount predicted by age. No significant difference was found between
measured and expected p16INK4a expression for tubular cell nuclei.
Table 4 | Univariate and multivariate linear regression analyses for nuclear p16INK4a expression in glomeruli, tubules,
interstitium, and arteries
Glomeruli Interstitium Tubules Arteries
p16INK4a expression R2 P-value R2 P-value R2 P-value R2 P-value
Univariate linear regression analysis
GD vs no GDa 0.372 o0.001 0.258 o0.001 0.065 0.22 0.020 0.27
TIN vs no TINb 0.372 0.55 0.258 0.28 0.065 0.40 0.020 0.55
GD vs TIN 0.214 0.001 0.103 0.02 0.063 0.08 0.002 0.77
Age 0.062 0.04 0.044 0.09 0.066 0.03 0.070 0.03
Serum creatinine at biopsy 0.045 0.08 0.035 0.13 0.036 0.12 0.009 0.44
Proteinuria 0.159 0.001 0.132 0.003 0.011 0.40 0.005 0.59
IF/TA 0.127 0.003 0.098 0.01 0.000 0.89 0.026 0.20
Inflammation 0.028 0.17 0.125 0.004 0.000 0.99 0.290 0.17
FIT 0.009 0.44 0.001 0.79 0.012 0.39 0.000 0.97
Global glomerulosclerosis 0.004 0.62 0.005 0.57 0.017 0.30 0.004 0.61
Multivariate linear regression analysis, P-value
GD vs no GDa o0.001 0.01 0.49 0.96
TIN vs no TINb 0.17 0.09 0.43 0.51
GD vs TIN 0.002 0.001 0.050 —
Age 0.12 0.35 0.01 0.07
Serum creatinine at biopsy 0.12 0.06 0.058 —
Proteinuria 0.85 0.38 — —
IF/TA 0.50 0.12 — 0.98
Inflammation 0.25 0.001 — 0.46
FIT, fibrous intimal thickening in arteries; GD, glomerular disease; IF, interstitial fibrosis; TA, tubular atrophy; TIN, tubulointerstitial nephritis.
Bold P-values are less than 0.05.
aNo GD, includes normals and TIN.
bNo TIN, includes normals and GD.
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DISCUSSION
Our results indicate that GD may act as an environmental
stress inducing senescence in glomerular and interstitial cells,
which in turn may contribute the progression by arresting
replication needed to sustain the glomerulus. Kidneys with
GD displayed a greatly increased expression of senescence
marker p16INK4a in glomerular and interstitial cell nuclei and
tubular cytoplasm compared to normal kidneys or those with
TIN. In multivariate analysis, GD itself accounted for the
increased p16INK4a expression in glomeruli and interstitial
cells. These relationships are likely to be complex: GD causes
proteinuria, which was also associated with p16INK4a expres-
sion. We do not know why the level of proteinuria did not
correlate with p16INK4a expression, but the stresses related to
GD itself and proteinuria are probably not dissectible and
both may cooperate in inducing senescence. Perhaps the
proteinuria would have been expected to induce p16INK4a
expression in tubular nuclei, but this did not occur.
Nevertheless, proteinuria may link between GD to p16INK4a
expression in interstitial cell nuclei and tubular cytoplasm:
filtered proteins injure tubular epithelial cells and trigger pro-
inflammatory and pro-fibrotic effects.11,12
It is noteworthy that the location and amount of p16INK4a
expression is similar in both immune complex GD (MGP)
and non-immune complex mediated GD (FSGS, MCD). In
normal human glomeruli, we observed p16INK4a staining in
all resident cell types, including mesangial cells, endothelial
cells, podocytes, and parietal cells, and its expression
increased with age. Biopsies with MGP, FSGS, and MCD
showed higher p16INK4a expression than normals or TIN
kidneys, notably in mesangial–endothelial cells. Although the
underlying pathogenetic mechanisms are different, the
amount of p16INK4a expression in mesangial–endothelial
cells, podocytes, and parietal epithelium was similar in both
immune complex GD and non-immune GD.
Another interesting finding in the present study is the
diffuse and global pattern of p16INK4a expression in FSGS.
The p16INK4a expression in the glomeruli affected by FSGS
was mainly observed in non-sclerotic tuft areas. Although
FSGS is a focal disease, these observations suggest that the
stresses related to disease processes induce a more diffuse and
global p16INK4a expression in glomeruli, which is not limited
to the glomeruli affected by focal sclerosis. It is known that
podocyte alterations in FSGS are relatively diffuse and global
at the electron microscopy level, although the lesions are focal
and segmental at the light microscopy level.14
The regulation of the cell-cycle by proteins such as cyclin-
dependent kinase inhibitors determines the cellular response
to various immune and non-immune injury, and thus the
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Figure 3 | The effect of disease stress of glomerular disease on
p16INK4a expression in glomerular cells was dominant to the effect of
age and TIN. Multivariate linear regression analysis of 19 normal
kidneys, 12 tubulointerstitial nephritis, and 35 glomerular disease
biopsies revealed that GD is the best contributor of accelerated
p16INK4a expression in glomeruli (Po0.001).
Table 5 | Comparison of nuclear p16INK4a positivity scores in
normal kidneys, GD, and TIN according to the glomerular cell
types
p16INK4a positive cell type Score Normal kidney GD TIN
Mesangial–endothelial cells 0–1 17 (90%) 21 (60%) 10 (83.3%)
2–3 2 (10%) 14 (40%)* 2 (16.7%)
Parietal cells 0–1 19 (100%) 32 (91%) 11 (91.7%)
2–3 — 3 (9%) 1 (8.3%)
Podocytes — 11 (58%) 16 (46%) 8 (66.7%)
+ 8 (42%) 19 (54%) 4 (33.3%)
GD, glomerular disease; TIN, tubulointerstitial nephritis.
*P=0.04, w2 test.
Table 6 | Distribution of p16INK4a among GD groups
p16INK4a expression (%, mean7s.d.)
MGP (n=22) FSGS (n=8) MCD (n=5)
Glomeruli-N 17.9712.4 18.2713.4 11.879.9
Tubules-N 22723.5 10.777.2 7.377.6
Tubules-Ca 1.471 1.670.7 0.670.8
Interstitium-N 32.5725.4 25.1722.6 27.4723.3
Vessels-Na 0.670.6 0.570.3 0.270.2
C, cytoplasmic staining; FSGS, focal segmental glomerular sclerosis; GD, glomerular
disease; MCD, minimal change disease; MGP, membranous glomerulopathy; N,
nuclear.
Kruskal–Wallis test, P40.05.
ap16INK4a positivity scores (mean7s.d.).
Table 7 | Localization and quantitative assessment of nuclear
p16INK4a expression in glomerular cell types in GD groups
p16INK4a expression a (%, mean7s.d.)
P16INK4a-positive cell type MGP (n=22) FSGS (n=8) MCD (n=5)
Mesangial–endothelial cells 12.2711.8 14.2712.3 6.777.5
Parietal cells 3.473.7 3.672.4 2.171.6
Podocytes 3.572.9 2.772.7 2.572.1
FSGS, focal segmental glomerular sclerosis; GD, glomerular disease; MCD, minimal
change disease; MGP, membranous glomerulopathy.
ap16INK4a expression is given as the percentage of p16INK4a-positive mesangial–en-
dothelial or podocyte or parietal cell nuclei according to the total number of nuclei
in 10 randomly counted glomeruli. Kruskal–Wallis test, P40.05.
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development of histopathological lesions.15–17 Shankland
et al.16 suggested that the role of each cell-cycle regulator
protein is cell-type specific and dependent on the type of
injury. The proliferation of rat mesangial cells induced by
platelet-derived growth factor was significantly inhibited by
p16INK4a and moderately inhibited by p21WAF1.18 In human
diseases without podocyte proliferation (MCD, MGP),
p21WAF1, p27KIP1, and p57KIP2 expression did not change.
In contrast, in diseases with podocyte proliferation (cellular
FSGS, HIV-associated nephropathy) there was decreased
p27KIP1 and p57KIP2 expression with an increase in p21WAF1
expression by podocytes.19 These results underscore the
complex roles of cyclin-dependent kinase inhibitors in renal
diseases.
The pattern and location of p16INK4a expression may be an
indicator of the primary site of injury in chronic renal
disease. Aged kidneys display increased nuclear p16INK4a
expression in tubules, glomeruli, interstitium, and vessels,
and some show tubular cytoplasmic staining for p16INK4a,
which is not observed in young kidneys.4 Kidney transplants
with IF/TA manifested increased p16INK4a expression in
interstitial, glomerular, tubular cell nuclei, and tubular
cytoplasm beyond normal aging.1 In this study, native
kidneys with GD showed increased p16INK4a expression in
glomerular and interstitial cell nuclei, and tubular cytoplasm,
which further confirms our previous findings. On the other
hand, tubular nuclear p16INK4a staining in GD biopsies was
similar to the amount predicted for age. TIN biopsies showed
an increased p16INK4a staining in interstitial cell nuclei and
tubular cytoplasm but not in glomeruli. Perhaps somatic cell
senescence and irreversible cell-cycle arrest prevent one renal
compartment from sustaining itself, leading to nephron loss
as further insults accrue.
The tubular cytoplasmic p16INK4a staining observed in
kidneys with GD and TIN was beyond the changes of normal
aging, suggesting that the stress of proteinuria or of TIN may
induce this change in tubular epithelium. Cytoplasmic
p16INK4a staining was previously observed in various cancer
types.20–24 However, localization in non-neoplastic cells is
unclear. Here, we observed tubular cytoplasmic staining not
only in cells with nuclear staining or vice versa, which may be
compatible with dysregulation of the nuclear transport
mechanism or a mislocalization owing to overexpression.
As a small protein, p16INK4a may freely diffuse in and out of
the nucleus to interact with its partners.20 Thus, excess
production, abnormal nuclear transport, and decreased
catabolism may all contribute to increased tubular cytoplas-
mic p16INK4a staining, possibly indicating cells subjected to
unique disease stresses.
On the basis of the association of p16INK4a expression in
aged kidneys,4 damaged kidney transplants,1 and GD with
proteinuria, we hypothesize that injury exhausts finite
replicative capacity in key cell populations, triggering
p16INK4a expression and irreversible loss of replicative ability
and thus repair capacity. This in turn will contribute to loss
of nephrons in the face of continuing stress. Senescent cells
may drop out completely or persist, for example, in atrophic
tubules or interstitial cells, with persisting cells potentially
adding to dysfunction in the tissue.5 Either cell loss or cell
dysfunction in a nephron may trigger the regulatory systems
that prevent nephrons from operating when glomerular–
tubular balance is disturbed, leading to nephron shutdown.
This would mean that the sequence is ‘injury–p16INK4a–nephron
loss’. However, p16INK4a could also follow obsolescence,
providing a way of preventing harmful behaviors of cells from
nephrons that are no longer functioning. Thus, the seque-
nce ‘injury–nephron shutdown–p16INK4a expression’ is also
possible.
In summary, this study shows that kidneys with GD and
proteinuria display an accelerated expression of p16INK4a in
glomerular and tubulointerstitial compartments, correlating
with the degree of IF/TA, thus suggesting a role for somatic
cell senescence in progress of GD. It will also be interesting to
learn how somatic cell senescence mechanisms are balanced
against the other options of damaged renal epithelium, such
as epithelial–mesenchymal transition or apoptosis.
MATERIALS AND METHODS
Patients
Glomerular disease cases. A total of 31 patients (mean age
47.9, range 15–87) biopsied during the period of 1996–2003 for
investigation of proteinuria, with or without renal insufficiency were
included. The magnitude of proteinuria based on 24-h urine
collections at the time of renal biopsy and serum creatinine levels
were recorded. Thirty-five biopsy of 31 patients were diagnosed as
MGP (N¼ 22), FSGS (N¼ 8), and MCD (N¼ 5). Of the 22 MGP
cases, five were stage I, 11 stage II, five stage III, and one was stage
IV. The pertinent clinical data from the medical records of patients
with MGP (n¼ 19) were reviewed to determine whether MGP is
idiopathic or associated with an underlying disease: Twelve (63%)
were idiopathic and seven (37%) were presumed to be secondary
MGP (one is associated with adenocarcinoma of the lung, two with
hepatitis B or C infection, one with systemic lupus erythematosis, one
with rheumatoid arthritis, and two with diabetes mellitus type I or II).
Tubulointerstitial diseases. Twelve native kidney biopsies were
selected from patients with impaired renal function, diagnosed with
TIN: acute TIN (n¼ 6), acute and chronic TIN (n¼ 3), and chronic
TIN (n¼ 3).
Controls. Nineteen normal human kidney tissue samples were
obtained from zero biopsies at the time of transplantation
(implantation biopsies).
All biopsies are reviewed and the amount of IF, TA, interstitial
inflammation, fibrous intimal thickening in arteries, the percentage
of global glomerulosclerosis, and the presence of mesangial matrix
increase and cellularity or glomerular inflammation (if any) are
recorded.
Equation for predicting p16INK4a expression with age
We previously described a study of 42 human kidney samples,
mostly nephrectomy specimens from patients with kidney tumors,
in which we calculated the observed increase in p16INK4a with age.4
To adjust for age differences among the groups in the current study,
we used that equation to calculate the expected nuclear staining of
p16INK4a in the present cases.
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Ethics
The study was covered by approval (Protocol No. 2627) from the
Institutional Review Board (Health Research Ethics Board, Uni-
versity of Alberta, Edmonton, Alberta, Canada).
Immunoperoxidase staining for p16INK4a
Immunoperoxidase staining for p16INK4a was performed using 2 mM
sections of paraffin embedded tissue. Briefly, sections were
deparaffinized and rehydrated. The sections were immersed in 3%
H2O2 in methanol to inactivate endogenous peroxidase. Slides were
blocked with 20% normal goat serum. Tissue sections were then
incubated for 1 h at room temperature with the primary antibody
(mouse monoclonal antibody, Clone F-12, Santa Cruz Biotechnol-
ogies, Santa Cruz, CA, USA) and rinsed with phosphate-buffered
saline. Following 30 min of incubation with the Envision
Monoclonal System (Dako, Mississauga, Ontario, Canada),
sections were washed again in phosphate-buffered saline. Visualiza-
tion was performed using the DAB substrate kit (Dako, Mississauga,
Ontario, Canada). The slides were counterstained with hematoxylin
and mounted. Tonsil was used as a positive control and sections
stained with immunoglobin G isotype were used as a negative
control.
Analysis was carried out by counting 10 high-power fields.
Percentage of positive nuclei was assessed for glomeruli, tubules, and
interstitium. In interstitium, fibroblast-like spindle cells with
positive staining were counted. Tubular cytoplasmic staining was
assessed by counting the percentage of tubular cross-sections that
showed positive cytoplasmic staining for p16INK4a and scored on a
scale from 0 to 3 as 450% positive (score 3), 25–50% positive
(score 2), o25% positive (score 1), and negative (score 0). Each
artery was graded on a scale from 0 to 3, with 0 being no staining, 1
up to 30% stained nuclei, 2 between 30 and 60% stained nuclei, and
3 more than 60% stained nuclei. The mean score was then calculated
for each section.
Localization of p16INK4a staining in glomerular cell types
Because of the difficulties in finding enough tissue for double
stainings with specific cell markers, the glomerular cell types were
identified morphologically. Because the distinction of mesangial
cells from endothelial cells may be difficult, even impossible, by
morphology alone, we defined cells lying within the mesangium and
along the inner walls of glomerular capillary loops as mesangial–
endothelial cells. Cells attached to the outer aspect of the glomerular
capillary loops and lying along the inner wall of Bowman’s capsule
were identified as podocytes and parietal cells, respectively. We are
aware of the fact that morphological assessment alone may not be a
very precise method for quantification of staining. On the other
hand, we think that it is helpful to show the overall pattern and
location of expression. This determination can be made with
considerable accuracy as it is clear which side of the basement
membrane cells are on. The exact determination of which cell are
endothelial and which mesangial is much more difficult (both on
the inner aspect of the basement membrane) and this is why these
two categories were combined. The morphological identification of
glomerular cell types has been also previously used to show the
differential expression and location of cyclin-dependent kinase
inhibitors in human GD.19
In glomeruli, p16INK4a positive nuclei were scored semiquantita-
tively according to cell types (0–3: negative, o25%, 25–50%,
450%). For podocytes, p16INK4a staining was only noted as 0:
negative or 1: positive. The semiquantitative analysis of p16INK4a
staining in glomerular cell types was carried out for normal kidneys,
GD, and TIN. Then, the glomerular p16INK4a staining in MGP,
FSGS, and MCD was analyzed separately and the percentage of
p16INK4a-positive mesangial–endothelial cell, podocyte, and parietal
cell nuclei in 10 glomeruli was determined.
Statistical analysis
Data analyses were performed using SPSS 12.0 (Chicago, IL, USA).
p16INK4a expression in normal kidneys, GD and TIN were compared
using Mann–Whitney U, Kruskal–Wallis or w2 test. Kruskal–Wallis or
w2 test were used to compare p16INK4a expression among different
glomerular diseases. Expected p16INK4a expression was calculated
using the regression formulas as published previously:4 glomerular
p16INK4a¼ 0.04 ageþ 2.40; tubular p16INK4a¼ 0.43 age0.47;
interstitial p16INK4a¼ 0.18 age1.25. Expected and measured
p16INK4a expression was also compared using paired t-test.
Univariate and multivariate linear regression analyses were used to
select the significant determinants of increased nuclear p16INK4a
expression. Cytoplasmic tubular p16INK4a staining was not entered
to the linear regression analysis because the values were categorical.
Univariate correlates of the nuclear p16INK4a expression with a
Po0.3 were entered into the multivariate model to determine the
best independent determinants of increased nuclear p16INK4a
expression. The cutoff P-value o0.3 for the multivariate analysis
was chosen arbitrarily. The level of significance was set at Po0.05.
All values are given as mean7s.d. unless noted otherwise.
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expression.
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